STRS Ohio’s Myovant Sciences Ltd. MYOV Stock Holding History

STRS Ohio’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,400	Closed	-$39K	–	2038
2017 Q1	$39K	Hold	3,400	–	–	﹤0.01%	1800
2016 Q4	$42K	Buy	+3,400	New	+$39.4K	﹤0.01%	1813

Other funds holding MYOV

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

STRS Ohio's MYOV Position: Q2 2017 in Review

STRS Ohio sold out of Myovant Sciences Ltd. (MYOV) in Q2 2017, closing a stake of 3,400 shares — an estimated $39K sold.

STRS Ohio first reported a position in MYOV in Q4 2016 and held it in 2 quarters. The position peaked at $42K in Q4 2016. 42 funds tracked by Wall St. Rank hold MYOV as of Q2 2017.

STRS Ohio reported no remaining Myovant Sciences Ltd. position as of Q2 2017 after selling out during the quarter.
STRS Ohio sold 3,400 Myovant Sciences Ltd. shares in Q2 2017, an estimated $39K.
STRS Ohio first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 2 quarters.
STRS Ohio's Myovant Sciences Ltd. position peaked at $42K in Q4 2016.
42 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2017.

Based on STRS Ohio's 13F filing for Q2 2017, filed 26 Jul 2017.